TP53 and ovarian carcinoma: EnOC is a relatively under-investigated type of ovarian cancer; recently, molecular subtypes of EnOC have been described at the genomic and protein expression level—by TP53 and CTNNB1 mutation status, and by patterns of hormone receptor expression—and these have been associated with distinct clinicopathological features and survival outcome23,24.